The diverse molecular pathways related to CRC, like JAK/STAT, Wnt/β catenin, EMT, PI3K/AKT, and mTOR, can be regulated by bioactive compounds promoting apoptosis, inhibiting or decreasing cell growth and proliferation, reducing inflammation, eliminating cancer stem cells, and avoiding chemoresistance. Here, AKT1 is linked to colorectal carcinoma.